Shares of Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) have received an average recommendation of “Buy” from the seven research firms that are covering the company, Marketbeat reports. Two analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have issued ratings on the stock in the last […]